INFLARX N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 USD | -2.10% |
|
+16.67% | -14.11% |
| 05-08 | InflaRx N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-21 | Transcript : InflaRx N.V. - Special Call |
Chart calendar InflaRx N.V.
0.QFx7wg4lUkSHjPZcODcHBTjJ24QIi2Z2iOQvlkAvhiU.FGQWuEVnPRTSus4GD35VQmmmlPYw5hImxL5N3nJfvxEvaUumR3Nhcr_ThQ~24f2eb079a0b5beb77401399dbe51248
Upcoming events on InflaRx N.V.
Past events on InflaRx N.V.
| 2024-05-14 14:30 | Capital One Securities Biotech Conference - Panel |
| 2024-05-08 07:30 | Q1 2024 Earnings Release |
| 2024-03-21 08:00 | Q4 2023 Earnings Call |
| 2024-03-21 07:00 | Q4 2023 Earnings Release |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2024-01-04 08:30 | INF904 Phase I Study Results Call |
| 2023-11-28 16:30 | Piper Sandler Healthcare Conference |
| 2023-11-05 | Bio-Europe Conference |
| 2023-11-05 | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-11-01 07:30 | Q3 2023 Earnings Release |
| 2023-09-13 16:30 | Complement Based Drug Development Summit - Panel |
| 2023-09-12 17:10 | Complement Based Drug Development Summit |
| 2023-09-11 11:00 | H.C. Wainwright Global Investment Conference |
| 2023-09-11 08:30 | INF904 Phase I Study Results Call |
| 2023-09-10 | BioPharm America Conference |
| 2023-09-07 11:20 | World Antimicrobial Resistance Congress |
| 2023-08-10 07:30 | Q2 2023 Earnings Release |
| 2023-05-11 07:30 | Q1 2023 Earnings Release |
| 2023-04-26 03:00 | Annual General Meeting |
| 2023-04-05 08:30 | Business Update Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 3,20 - | 0,06 1,33 -95.25% | 0,41 |
|
EBITDA Million EUR | Released Forecast Spread | -56,1 -58,5 4.09% | -33,2 -34,0 2.26% | -47,0 -49,6 5.31% | -31,6 -65,0 51.32% | 0,00 0,00 - | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | -56,8 -59,4 4.45% | -33,9 -32,8 -3.33% | -47,6 -48,5 1.83% | -32,2 -47,3 31.83% | -44,9 -47,8 6.11% | -52,1 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -53,3 -56,0 4.87% | -34,0 -32,1 -5.98% | -45,6 -46,9 2.8% | -29,5 -35,9 17.82% | -42,7 -37,3 -14.3% | -46,3 |
|
Net income Million EUR | Released Forecast Spread | -53,3 -55,5 4.1% | -34,0 -32,5 -4.55% | -45,6 -42,7 -6.88% | -29,5 -35,2 16.24% | -42,7 -37,4 -14.03% | -46,4 |
|
EPS EUR | Released Forecast Spread | -2,05 -2,11 2.82% | -1,26 -1,14 -11.01% | -1,10 -1,05 -5.13% | -0,67 -0,80 15.83% | -0,78 -0,69 -13.45% | -0,74 |
| Announcement Date | 29/04/20 | 25/03/21 | 24/03/22 | 22/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,06 2,40 -97.47% | 0,00 1,25 -99.82% | 0,04 0,13 -72.77% | 0,09 | 0,09 | 0,20 | 0,00 | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -14,7 -14,0 -5.04% | |||||||||||||
|
EBIT Million EUR | Released Forecast Spread | -14,9 -14,7 -1.39% | -1,09 -13,3 91.82% | -8,59 -13,1 34.47% | -7,70 -10,7 27.76% | -10,6 -12,2 13.33% | -9,86 -19,5 49.52% | -11,2 -14,9 25.33% | -13,3 -12,0 -10.64% | -12,5 -13,0 3.9% | -12,6 | -13,0 | -14,0 | -18,3 | -20,0 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -14,0 -14,4 2.53% | 0,47 -11,1 104.18% | -7,92 -13,1 39.33% | -8,03 -10,4 22.83% | -11,1 -12,2 9% | -8,20 -18,0 54.44% | -7,45 -13,8 45.85% | -15,9 -10,7 -48.35% | -9,66 -13,4 28.15% | -11,5 | -12,0 | -13,1 | -17,6 | -19,3 |
|
Net income Million EUR | Released Forecast Spread | -14,0 -14,3 2.2% | 0,47 -13,3 103.5% | -7,92 -13,6 41.64% | -8,03 -10,7 24.64% | -11,1 -12,0 7.52% | -8,20 -18,2 54.95% | -7,45 -13,8 45.99% | -15,9 -10,7 -49% | -9,66 -13,3 27.13% | -11,7 | -12,1 | -12,9 | -17,6 | -19,3 |
|
EPS EUR | Released Forecast Spread | -0,32 -0,32 1.11% | 0,01 -0,30 103.33% | -0,18 -0,33 44.62% | -0,18 -0,25 28% | -0,25 -0,27 8.54% | -0,14 -0,31 55.2% | -0,13 -0,24 45.26% | -0,28 -0,18 -53.42% | -0,17 -0,22 23.6% | -0,20 | -0,19 | -0,19 | -0,25 | -0,24 |
| Announcement Date | 12/05/22 | 05/08/22 | 09/11/22 | 22/03/23 | 11/05/23 | 10/08/23 | 01/11/23 | 21/03/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for InflaRx N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IFRX Stock
- Calendar InflaRx N.V.